Delisting riskPopularity #4,543
MDXH · NASDAQ · Medical - Diagnostics & Research

MDxHealth (MDXH)

Molecular prostate-cancer tests for testing and treatment decisions.

$0.5960
vs last close−0.00 (−0.65%)